Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Updates in osteogenesis imperfecta].

Leonid Zeitlin1, Shlomo Wientroub, Nehemia Blumberg

  • 1Departments of Pediatric Orthopaedics, Dana Children's Hospital, Israel.

Harefuah
|October 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world growth outcomes of vosoritide in children with achondroplasia: a single-center cohort study.

Journal of the Endocrine Society·2026
Same author

The framework and best practices of emergency medical teams: lessons learned from Israel's international field hospital response.

Israel journal of health policy research·2026
Same author

Burosumab in infants with X-linked hypophosphatemic rickets: a case series.

Orphanet journal of rare diseases·2026
Same author

The importance of collecting and sharing scientific publications in pediatric orthopedic surgery from China.

Journal of children's orthopaedics·2025
Same author

Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study.

Frontiers in pediatrics·2024
Same author

Heterozygous mutations in the straitjacket region of the latency-associated peptide domain of TGFB2 cause Camurati-Engelmann disease type II.

Journal of human genetics·2024
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Osteogenesis Imperfecta (OI) is a group of inherited bone disorders causing fragility and low bone mass. Advances in understanding OI

Area of Science:

  • Genetics
  • Molecular Biology
  • Histology

Context:

  • Osteogenesis Imperfecta (OI) is a heterogeneous group of inherited disorders.
  • Characterized by bone fragility and low bone mass.
  • Significant advancements in understanding OI's molecular, histological, and genetic pathogenesis have occurred since the Sillence classification.

Purpose:

  • To summarize the current understanding of Osteogenesis Imperfecta's pathogenesis.
  • To highlight the expanded nosology of OI.
  • To emphasize the benefits of a multidisciplinary approach in managing OI.

Summary:

  • Progress in molecular, histological, and genetic research has expanded the classification of Osteogenesis Imperfecta.
  • Understanding the pathogenesis has evolved significantly.

Related Experiment Videos

  • A multidisciplinary approach is crucial for managing OI.

    • Impact:

    • Improved quality of life for patients with Osteogenesis Imperfecta.
    • Prolonged life expectancy for individuals with OI.
    • Enhanced management strategies through a multidisciplinary approach.